Deep Track Capital, LP - 30 Jan 2026 SCHEDULE 13G Report for ProMIS Neurosciences Inc. Common Shares, no par value per share (PMN)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
ProMIS Neurosciences Inc. Common Shares, no par value per share
Symbol
PMN
Shares outstanding
9,034,645 shares
Disclosed Ownership
902,561 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
06 Feb 2026, 16:00:23 UTC
Date of event
30 Jan 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Deep Track Capital, LP disclosed 10% ownership in ProMIS Neurosciences Inc. Common Shares, no par value per share (PMN) on 30 Jan 2026."

Quick Takeaways

  • Deep Track Capital, LP filed SCHEDULE 13G for ProMIS Neurosciences Inc. Common Shares, no par value per share (PMN).
  • Disclosed ownership: 10%.
  • Date of event: 30 Jan 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 06 Feb 2026, 16:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 10% 902,561 0 902,561 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 7.8% 703,457 0 703,457 /s/ David Kroin David Kroin, Director
David Kroin 10% 902,561 0 902,561 /s/ David Kroin David Kroin
Deep Track Special Opportunities Fund, LP. 2.2% 199,104 0 199,104 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser of Deep Track Special Opportunities Fund, LP

Sponsored